Literature DB >> 3128878

Plasma apolipoprotein C-III levels in children with type I diabetes.

P Blackett1, D C Sarale, J Fesmire, J Harmon, P Weech, P Alaupovic.   

Abstract

The serum concentrations of apolipoproteins C-III, B, and A-I were determined in children with type I diabetes mellitus to establish whether they correlated with the level of glycosylated hemoglobin (Hb A1) and to determine whether these values differ between diabetic children and a population of normal children. Triglyceride (TG), total cholesterol (TC), and apolipoprotein (Apo) levels were studied in 95 children with type I diabetes; 51 of the children were attending a diabetes clinic and 44 were attending a diabetes summer camp. The level of Hb A1 correlated with Apo C-III (P less than .001) and TC (P less than .001) values in the clinic group, but not with Apo A-I or TG levels in either group. The Apo C-III level was higher in both groups of diabetic children (8.0 +/- 0.5 and 9.5 +/- 0.4 mg/dl) (P less than .01) than in normal subjects (6.1 +/- 0.2 mg/dl). We conclude that the Apo C-III level tends to be higher in diabetics than in normal subjects, even in the normotriglyceridemic camp group. The Apo C-III level correlated with both the TC level and Hb A1, suggesting that Apo C-III determinations in type I diabetic patients may permit early identification of atherosclerotic risk.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128878     DOI: 10.1097/00007611-198804000-00015

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.

Authors:  Lisa Juntti-Berggren; Essam Refai; Ioulia Appelskog; Mats Andersson; Gabriela Imreh; Nancy Dekki; Sabine Uhles; Lina Yu; William J Griffiths; Sergei Zaitsev; Ingo Leibiger; Shao-Nian Yang; Gunilla Olivecrona; Hans Jörnvall; Per-Olof Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

2.  Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria.

Authors:  Fanny Jansson Sigfrids; Lars Stechemesser; Emma H Dahlström; Carol M Forsblom; Valma Harjutsalo; Raimund Weitgasser; Marja-Riitta Taskinen; Per-Henrik Groop
Journal:  J Intern Med       Date:  2021-11-24       Impact factor: 13.068

Review 3.  Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle.

Authors:  Ismael Valladolid-Acebes; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.